Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Army
Johnson and Johnson
Cipla
QuintilesIMS
Boehringer Ingelheim
Fish and Richardson
Merck
Citi
Cerilliant

Generated: October 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,543,150

« Back to Dashboard

Summary for Patent: 5,543,150

Title: Method of progesterone delivery and affect thereof
Abstract:The present invention teaches that relatively low levels of serum progesterone, 1 to 6 ng/ml, may be used to prevent endometrial cancer. The vaginal delivery of progesterone using a cross-linked polycarboxylic polymer produces this low serum progesterone level while also providing the full secretory transformation of the endometrium, indicating the efficacy of the progesterone. Such low levels of serum progesterone will decrease the risk of breast cancer experienced by women undergoing hormone replacement therapy ("HRT") and minimize the potential of other undesirable progesterone associated side effects.
Inventor(s): Bologna; William J. (New York, NY), Levine; Howard L. (Oceanside, NY)
Assignee: Columbia Laboratories, Inc. (Coconut Grove, FL)
Application Number:08/122,371
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;

No matches for this query

International Patent Family for Patent: 5,543,150

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2171939► Subscribe
Colombia4290332► Subscribe
Germany69415543► Subscribe
Denmark0719146► Subscribe
European Patent Office0719146► Subscribe
Spain2126783► Subscribe
Finland961221► Subscribe
Finland115444► Subscribe
Greece3029314► Subscribe
Hungary9600669► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
QuintilesIMS
Chubb
Healthtrust
Cantor Fitzgerald
Harvard Business School
Novartis
Cerilliant
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot